V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20156742 | 20087907 | 0 | 69.8 | 03 | 2019-08-09 | 2019-09-06 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | RADIUM 223 | 100947123 |
| 20156802 | 20087908 | 0 | 86.3 | null | 2019-08-28 | 2019-08-28 | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 01 | N | CAPECITABINE + CARBOPLATIN + RT | 101249647 |
| 20156982 | 20087911 | 1.55 | 93 | null | 2019-02-19 | 2019-02-25 | Gemcitabine + Paclitaxel | 01 | N | ARISTOTLE TRIAL | 101543008 |
| 20157011 | 20087912 | 1.71 | 62.2 | null | 2018-06-23 | 2018-07-17 | ARISTOTLE TRIAL | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101120671 |
| 20157055 | 20087913 | 1.68 | 66 | Palliative (P) | 2019-09-26 | 2019-10-05 | Cisplatin +FU +Trastuzumab - Load | 01 | N | EOF | 100365917 |
| 20157177 | 20087914 | 1.79 | 98.4 | 03 | 2019-01-06 | 2019-01-07 | PLATO Trials | 02 | N | PLATO TRIAL | 101243634 |
| 20157219 | 20087915 | 1.54 | 69.65 | 03 | 2020-08-31 | 2020-09-19 | Hepatoblastoma Relapse VI | 02 | N | DOCETAXEL | 101073638 |
| 20157247 | 20087916 | 1.77 | 55.9 | Palliative (P) | null | 2020-10-12 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | CETUXIMAB + ENCORAFENIB | 101484743 |
| 20157251 | 20087917 | 1.64 | 51.4 | 03 | 2016-03-02 | 2016-03-30 | FCarboSt | 02 | N | PANTHER TRIAL | 100624380 |
| 20157299 | 20087918 | 1.75 | 64.55 | null | 2019-01-21 | 2019-01-22 | Hydroxycarbamide | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100885558 |
| 20157300 | 20087919 | 1.71 | null | Palliative (P) | 2017-02-08 | 2017-02-19 | OXALIPLATIN + MDG + PANITUMUMAB | null | N | GEMCARBO | 101163952 |
| 20157327 | 20087920 | 1.77 | 105 | Palliative (P) | 2019-12-16 | 2020-01-03 | EVEROLIMUS | 02 | N | PHITT B OR C CISPLATIN | 101108371 |
| 20157467 | 20087922 | 1.69 | 72 | 03 | 2018-02-08 | 2018-02-28 | Paclitaxel 7 day | 02 | N | RITUXIMAB | 101312985 |
| 20157513 | 20087923 | 1.75 | 64.5 | Palliative (P) | null | 2019-12-09 | FCarboSt | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100089083 |
| 20157596 | 20087924 | 1.65 | 70.95 | 03 | 2017-09-20 | 2017-10-04 | EP | 01 | N | CAP + RT | 100080821 |
| 20157770 | 20087925 | 1.67 | 59 | Adjuvant (A) | 2019-06-15 | 2019-06-19 | PEMBROLIZUMAB | 2 | N | NIVOLUMAB | 100642086 |
| 20157828 | 20087926 | 1.7 | 68 | 03 | 2017-03-18 | 2017-03-18 | Azacitidine | 02 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100920542 |
| 20157887 | 20087927 | 0 | 0 | Curative (C) | 2018-11-07 | 2018-11-14 | Docetaxel | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100339210 |
| 20157964 | 20087928 | 1.7 | 68 | 03 | 2017-04-02 | 2017-04-06 | Carboplatin + Vinorelbine Oral | 02 | N | RIBOCICLIB | 101178447 |
| 20158004 | 20087929 | 1.76 | 84.5 | Palliative (P) | 2017-12-13 | 2017-12-16 | Carbo F | 02 | N | MITOMYCIN | 101303035 |
| 20158038 | 20087930 | 1.7 | 78 | Adjuvant (A) | 2019-03-20 | 2019-03-20 | Doxorubicin + Olaratumab | 02 | N | PAZOPANIB | 101558055 |
| 20158065 | 20087931 | 1.92 | 14.8 | Palliative (P) | null | 2020-10-02 | CVP R | 01 | N | EOF | 100839297 |
| 20158301 | 20087933 | 1.59 | 100 | 03 | null | 2017-05-23 | Abiraterone | 01 | N | DABRAFENIB + TRAMETINIB | 101571546 |
| 20158323 | 20087934 | 1.73 | 88 | Curative (C) | 2018-03-28 | 2018-04-23 | Bendamustine+Rituximab (1st Course) | 02 | Y | HEP HR HEPATOBLASTOMA GUIDE CISP | 101815356 |
| 20158340 | 20087935 | 1.55 | 68 | Palliative (P) | 2015-03-06 | 2015-03-10 | Panitumumab | 02 | N | FCIST | 101683477 |
| 20158397 | 20087936 | null | 79.4 | 03 | null | 2019-06-16 | PLATO Trials | null | N | PLATO TRIAL | 100985570 |
| 20158411 | 20087937 | 1.77 | 82.8 | 03 | 2017-06-07 | 2017-07-05 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | AZACITIDINE | 101082213 |
| 20158509 | 20087938 | 1.7 | 65 | 03 | 2019-08-14 | 2019-08-14 | NAB PACLITAXEL | 01 | N | ESPAC TRIAL | 100658098 |
| 20158558 | 20087939 | 1.65 | 77 | Palliative (P) | 2017-10-23 | 2017-10-23 | Doxorubicin 75mg/m2 | 01 | N | DOCETAXEL | 100114796 |
| 20158584 | 20087940 | 1.77 | 50 | Palliative (P) | 2018-05-24 | 2018-05-24 | OXALIPLATIN | 02 | N | FOXTROT TRIAL | 101149928 |
| 20158621 | 20087941 | 1.69 | 63 | null | 2019-11-24 | 2019-12-08 | Rituximab | N | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101435620 |
| 20158965 | 20087942 | 1.84 | 72.4 | 03 | 2018-07-11 | 2018-07-11 | Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101443493 |
| 20159094 | 20087943 | 1.78 | 90 | Palliative (P) | 2019-04-11 | 2019-04-26 | CARBOPLATIN + EPIRUBICIN | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101121232 |
| 20159135 | 20087944 | 1.88 | 101 | Palliative (P) | 2018-01-13 | 2018-02-19 | ACTICCA-1 Trial | 02 | N | PLATO TRIAL | 100820055 |
| 20159169 | 20087945 | 1.7 | 84.5 | Palliative (P) | 2016-11-01 | 2016-11-01 | PLATO Trials | 99 | N | PLATO TRIAL | 100933100 |
| 20159217 | 20087946 | 1.73 | 69 | 03 | 2016-03-29 | 2016-04-17 | CISPLATIN + VINORELBINE | 02 | N | EOF | 100609557 |
| 20159318 | 20087947 | 1.82 | 65.5 | Palliative (P) | null | 2016-05-07 | Bortezomib + Panobinostat | N | N | ECARBOX | 101398261 |
| 20159362 | 20087948 | 1.88 | 80 | 03 | 2018-08-12 | 2018-08-12 | Irinotecan | N | N | FOXTROT TRIAL | 101603763 |
| 20159370 | 20087949 | 1.7 | 71 | Curative (C) | null | 2020-10-03 | NEO-AEGIS TRIAL | null | Y | OLAPARIB | 101429125 |
| 20159552 | 20087950 | 1.75 | 89 | Adjuvant (A) | 2018-08-07 | 2018-09-11 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101713550 |
| 20159558 | 20087951 | 0 | 0 | Adjuvant (A) | null | 2019-07-28 | OXALIPLATIN | 01 | N | CARBOPLATIN + PEMETREXED | 100141661 |
| 20159617 | 20087952 | 1.74 | 62.9 | Palliative (P) | 2021-04-03 | 2021-04-03 | IPILIMUMAB + NIVOLUMAB | N | Y | EOF | 100459460 |
| 20159702 | 20087953 | null | 57.8 | null | 2018-05-09 | 2018-05-19 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | SUNITINIB | 100838496 |
| 20159852 | 20087954 | 1.6 | 48.7 | Adjuvant (A) | 2017-03-07 | 2017-04-04 | null | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101569012 |
| 20159971 | 20087956 | 1.7 | 80.3 | null | 2017-12-21 | 2017-12-26 | ECarboX | 02 | N | ARISTOTLE TRIAL | 100288327 |
| 20159997 | 20087957 | 1.82 | 60.2 | 03 | 2009-05-03 | 2017-10-29 | ESPAC-4 TRIAL | 02 | N | RITUXIMAB | 100350157 |
| 20160014 | 20087958 | 1.67 | 76.8 | Palliative (P) | 2017-07-17 | 2017-08-11 | ARISTOTLE TRIAL | N | N | CYCLOPHOSPHAMIDE | 101748802 |
| 20160075 | 20087959 | 1.92 | 64 | 03 | 2018-06-17 | 2018-06-17 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | LENALIDOMIDE | 100883404 |
| 20160080 | 20087960 | 1.73 | 24.7 | Palliative (P) | 2018-02-28 | 2018-03-24 | Paclitaxel 7 day | 01 | N | EVEROLIMUS | 101015704 |
| 20160104 | 20087961 | 1.83 | 73.5 | Palliative (P) | 2016-02-26 | 2016-03-04 | Ralitrexed | 02 | N | SCOPE2 TRIAL | 100803207 |